On May 18, 2022 G1 Therapeutics, Inc. (Nasdaq: GTHX), a commercial-stage oncology company, reported that Jack Bailey, G1’s Chief Executive Officer, will provide a virtual corporate presentation during the H.C. Wainwright & Co. Global Investment Conference (Press release, G1 Therapeutics, MAY 18, 2022, http://investor.g1therapeutics.com/news-releases/news-release-details/g1-therapeutics-participate-hc-wainwright-co-global-investment [SID1234614793]). The presentation will become available at 7:00 AM EDT on May 24, 2022. This meeting is being held in person and virtually; the webcast of G1’s presentation will be accessible on the Events & Presentations page of View Source

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!